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Abstract
Prostate cancer is the most commonly diagnosed cancer in men,
however prognosis is relatively good given sufficiently early diagno-
sis. This motivates the need for fast and reliable prostate cancer
grading. In this study, we investigate the efficacy of a discovery
radiomics strategy for prostate zone-based cancer grading using a
deep radiomic sequencer discovered from diffusion weighted imag-
ing (DWI) data. More specifically, we propose Zone-DR, a discovery
radiomics approach based on zone-level deep radiomic sequencer
discovery that discover radiomic feature directly from DWI data. Ex-
perimental results using 12,466 pathology-verified zones obtained
from DWI data of 101 patients showed that the proposed Zone-
DR approach achieved higher accuracy than a threshold-based ap-
proach for both ADC and CHB-DWI. Furthermore, the results also
showed that the trade-off between sensitivity and specificity can be
optimized based on the particular clinical scenario we wish to em-
ploy Zone-DR for, such as clinical screening versus surgical plan-
ning.
1 Introduction
Prostate cancer is the most commonly diagnosed cancer in North
American men. Prognosis is relatively good given early diagnosis
[1], thus motivating the need for early screening. Diffusion weighted
imaging (DWI) has gained traction in recent years for prostate can-
cer screening. The most commonly used DWI modality currently
is apparent diffusion coefficient maps (ADC), with the recently in-
troduced computed high-b value diffusion weighted imaging (CHB-
DWI) showing considerable promise [2].
The current approach to prostate cancer screening using DWI
is a binary threshold-based strategy [3], which does not account
for variations of the imaging equipment and protocol, and variations
in signal characteristics of healthy and cancerous tissue in different
areas of the prostate amongst different individuals when captured
using DWI. In this study, we investigate the efficacy of ADC and
CHB-DWI when applied to 12,466 pathology-verified prostate zone
gradings from DWI data of 101 patients using a radiomics strat-
egy. More specifically, we propose Zone-DR, a discovery radiomics
approach based on zone-level deep radiomic sequencer discovery
that discover radiomic features directly from DWI data.
2 Method
Since this is the first study on prostate zone-based grading via dis-
covery radiomics, it is important to investigate and identify the ap-
propriate zone-level radiomic sequencer design for the DWI-derived
modalities being explored. To achieve this goal, we employ a
machine-driven radiomic sequencer discovery strategy, where we
perform Bayesian optimization (leveraging SigOpt’s conditional ex-
periment [4]) over a deep convolutional-based radiomic sequencer
design space to discover the best deep radiomic sequencer for
zone-based grading based on area under the curve (AUC) as the
objective function for each modality. The optimal radiomic se-
quencer designs that were discovered are shown in Table 1.
The zone-level deep radiomic sequencer, with the design shown
in Table 1, undergoes a radiomic sequencer discovery process to
learn all the parameters of the sequencer. The loss function used to
learn the parameters is binary cross-entropy. To account for grade
imbalance, grade weights of 1 and 95 are used for negative-grade
and positive-grade zones, respectively.
3 Results
Based on Table 2, Zone-DR achieves higher accuracy than the
threshold-based approach for both ADC and CHB-DWI. This sug-
gests that learning radiomic features directly from DWI data via
deep radiomic sequencer discovery is important for distinguishing
Table 1: Optimal zone-level radiomic sequencer designs discovered
for ADC and CHB-DWI
ADC CHB-DWI
input
conv3-15 conv3-10conv3-29
conv3-15 conv3-23conv3-46
conv3-18 conv3-106
flatten-288 flatten-1696
FC-341 FC-295
Table 2: AUC, specificity, sensitivity and accuracy for threshold-
based approach and Zone-DR
Modality Technique AUC Sensitivity Specificity Accuracy
Threshold 0.895 0.601 0.604ADC Zone-DR 0.858 0.874 0.737 0.738
Threshold 0.733 0.824 0.823CHB-DWI Zone-DR 0.882 0.828 0.873 0.873
between positive and negative zones. In addition, the use of CHB-
DWI with Zone-DR led to a higher AUC than ADC with Zone-DR.
The sensitivity, specificity and accuracy values reported for Zone-
DR were selected by choosing a point on the ROC curve that max-
imizes the sum of sensitivity and specificity. Using the chosen
point, the use of CHB-DWI led to highest specificity while the use
of ADC led to highest sensitivity, making the choice of modality and
weighting between sensitivity and specificity useful for different clin-
ical scenarios. For example, maximizing specificity is important for
surgery for removal of prostate where you want to minimize false
positive rates to avoid unnecessary surgeries. On the other hand,
for cancer screening, maximizing sensitivity may be useful to avoid
missing cancerous patients.
Based on the experimental results, it can be observed that the
proposed Zone-DR approach can provide significantly improved
cancer grading performance. Future research will look at a com-
bination of modalities to achieve better results, as well as different
deep radiomic sequencer designs.
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